Search
Search

| Catalog Number | Description |
|---|---|
| PB1055A | Brazier's Clostridium Difficile Selective Agar (HPA) |
Isolate and presumptively identify Clostridium difficile from clinical specimens with Thermo Scientific™ Oxoid™ Brazier's Clostridium Difficile Selective Agar (HPA). The presence of p-hydroxyphenylacetic acid in the medium promotes the production of p-cresol - a metabolite of C. difficile that produces a distinct odour to help in the presumptive identification. The addition of selective agents D-cycloserine and cefoxitin inhibit many bacteria that would normally be present in large numbers within fecal samples such as Enterobacteriaceae and Enterococcus faecalis.
Clostridium difficile was first isolated in 1935 by Hall and O’Toole1 who proposed the name ‘difficile’ because it was very difficult to isolate. Toxicogenic isolates of C. difficile have been demonstrated to be a major cause of antibiotic-associated ileo-caecitis in laboratory animals2 and pseudomembranous colitis in man3,4
Use Brazier’s Clostridium Difficile Selective Agar for the isolation and presumptive identification of Clostridium difficile from clinical samples.
Not all products are available for sale in all territories. Please inquire.
Remel™ and Oxoid™ products are now part of the Thermo Scientific brand.
General References: